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ABSTRACT 
 
BACKGROUND: 
 
 Hypoglycaemia is one of the most common metabolic problems seen in 
neonatal intensive care unit. The symptoms of hypoglycaemia in neonates are 
subtle. There is increased risk of neuromotor disability and intellectual 
disability among the survivors of symptomatic hypoglycaemia1. 
 Hence for early detection and treatment of hypoglycemia a reliable 
device is needed. In the laboratory, the blood glucose estimation is done using 
glucose oxidase method which is specific and precise for the estimation of 
glucose but the results are not immediately available. So glucose estimation is 
done using glucometer in the neonatal intensive care unit for immediate 
results.  
  Blood glucose estimated by glucometers correlates well with the 
laboratory values only in euglycemic and hyperglycemic states but it is less 
often useful in the hypoglycaemic range according to many studies 2.  
AIMS AND OBJECTIVES 
1. To estimate the blood glucose levels in sick newborn infants. 
2. To estimate the validate of the glucometer for detection of blood 
glucose levels in detecting hypoglycaemia. 
METHODS: 
 200 neonates admitted in NICU, GOVERNMENT RAJAH 
MIRASDAR HOSPITAL,Thanjavur Medical College, Thanjavur during a 
period of 6 months from January 2016 to July 2016. The glucose oxidase 
peroxidase method is done in the laboratory using venous sample. The blood 
glucose estimation was done by capillary and venous method using 
glucometer. Pearson correlation was used for statistical analysis. 
Hypoglycaemia is defined as the blood glucose level below 40mg/dl 3. The 
glucose oxidase peroxidase method is the gold standard based on which the 
sensitivity, specificity, and predictive value was calculated. 
RESULTS 
 In our study, of the 200 cases, 31 cases (15.5%) were hypoglycaemic, 
164 (82%) cases were euglycemic and 5 cases (2.5%) were hyperglycemic by 
laboratory glucose oxidase peroxidase method, which is taken as the gold 
standard. 
Capillary Blood glucose estimation using glucometer detected 23 cases 
(74.2%) of hypoglycaemia, 156 cases (95.1%) of euglycemiaand 5 cases 
(100%) of hyperglycemia in comparison with laboratory glucose oxidase 
peroxidase method. 
 Venous blood glucose estimation using glucometer detected 29 cases 
(93.5%) of hypoglycaemic, 158 cases (96.3%) of euglycemia and 3 cases 
(60%) of hyperglycemia in comparison with laboratory glucose oxidase 
peroxidase method. 
 Estimation of capillary blood glucose by glucometer was found to have 
a sensitivity of 74.19%, specificity of 98.2%, positive predictive value of 
88.4% negative predictive value of 95.4% and accuracy of 94.5% with 
statistically significant P value < 0.05. 
 Estimation of venous blood glucose using glucometer was found to 
have a sensitivity of 93.55%, specificity of 98.23 %, positive predictive value 
of 90.62% negative predictive value of 98.8% and accuracy of 97.5% with 
statistically significant P value < 0.05. 
CONCLUSION: 
1. Estimation of blood glucose using capillary and venous blood using 
glucometer have  strong  correlation with laboratory oxidase peroxidase 
method in detecting neonatal hypoglycaemia 
2. The sensitivity of detecting neonatal hypoglycemia by glucometer 
using venous blood is higher than capillary blood.  
KEYWORDS 
Hypoglycemia, neonates, glucometer, glucose oxidase method. 
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INTRODUCTION 
 The most important substrate for metabolism of brain is the peripheral 
blood glucose which is very essential for normal neurological function.In 
the newborn, the major metabolic derangement which leads to neurological 
sequelae and death is hypoglycaemia1, especially when it occurs in the first 
few days of birth. 
  The incidence of hypoglycemia in neonates varies from 0.2 to 11.4% 
overall4,5.This is more pronounced in rural areas were facilities for the 
detection of hypoglycemia and management of the condition are inadequate.  
 Symptoms of hypoglycaemia are non specific. So hypoglycaemia 
must be confirmed by laboratory estimation and also its response to 
treatment  as it  known to cause neuro developmental sequelae  and  
dysfunction of brain in both symptomatic and asymptomatic cases1,4,6. In the 
presence of certain risk factors like SGA, LGA,IDM,preterm, etc., the 
possibility of hypoglycaemia is found to increase many folds5.  
 However, when promptly suspected, diagnosed and treated the 
complications arising due to this condition can be prevented or minimised.   
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 Hence for the detection of hypoglycaemia many tools were identified 
and studies were conducted for estimating glucose much sooner to prevent 
the complications of hypoglycaemia.  
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OBJECTIVES 
1. To estimate the blood glucose levels in sick newborn infants 
2. To estimate the validate of the glucometer for detection of blood 
glucose levels in detecting hypoglycaemia 
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REVIEW OF LITERATURE 
HISTORICAL BACKGROUND 
 Reduced glucose concentration in the blood is termed as 
hypoglycemia. It was first described in the children 100 years back and in 
the newborn baby and older infants it was described 50 years7 back. 
 In spite of recent advances and technological development in the care 
of newborns, the correct definition, significance and treatment of 
hypoglycaemia in neonates still remains a controversy. 
 In neonates screening for hypoglycaemia was started only after test 
for blood glucose using reagent strips was developed in 1970. 
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GLUCOSE HOMEOSTASIS AT BIRTH 
 Glucose is the primary fuel for the fetus accounting for approximately 
80% of fetal energy consumption. The fetus has a continuous supply of 
glucose from the mother via the placenta and consequently fetal blood 
glucose levels are the same as the mothers8. The remaining 20% of fetal 
energy needs is provided by lactate, amino acids, ketones and other means. 
In uncomplicated pregnancy, the fetus is completely dependent on mother 
for its supply of glucose, for both energy productions, synthesis of other 
substrates. 
 Hepatic glycogen content is low9 in early gestation; a slow, 
continuous increase occurs between 15 and 20 weeks; and a rapid 
accumulation of glycogen in the liver is observed later. Fetal liver contains 
enzymes which are used in glucose production and glycogen breakdown 
process. These enzymes are activated by excessive maternal starvation. 
Fetal liver contains glycogen which is 3 times greater than adult liver. At 
birth, glycogen stores in the liver accounts for about 1% of the neonate’s 
energy reserve. 
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Glucose metabolism after birth 
 Glucose and oxygen are the main metabolic substrate of mature brain. 
At birth, the infant has to rapidly switch to endogenous gluconeogenesis 
until feeding is established. At birth the newborns blood glucose falls to 
approximately 75% of maternal blood glucose level. With the loss of the 
continuous infusion of glucose through the placenta, plasma glucose 
concentration in healthy term newborn falls during the first two hours after 
birth, reaching a nadir no lower than 40mg/dl, and then stabilises by           
4-6 hours of age in the range of 45-80 mg/dl10.  
 In the neonate the brain can use alternative metabolic fuels such as 
lactate and ketones. This is why the brain may be able to function normally 
or near normally, despite very low levels of blood glucose. The plasma 
glucose is maintained immediately after birth by the breakdown of hepatic 
glycogen in response to epinephrine and glucagon and it is facilitated by 
falling insulin levels11. 
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TABLE 1:  INSULIN EFFECTS IN GLUCOSE METABOLISM 
Action Effects 
  Glucose Uptake Into the Muscle Stimulates 
 Glucose Uptake into the adipose   
tissue 
Stimulates 
Adipose tissue {FFA release} Inhibits 
Glucose production Inhibits 
Ketone production Inhibits 
 
 However hepatic glycogen is depleted during 8-12 hours, after which 
plasma glucose levels are maintained by the synthesis of glucose from 
lactate, glycerol, amino acids and primarily alanine(gluconeogenesis). As 
feeds are established and carbohydrate intake is adequate, maintenance of 
plasma glucose concentrations is no longer solely depend on 
gluconeogenesis. 
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Adequate glucose output depends on: 
• Adequate glycogen stores 
• Sufficient gluconeogenetic precursors 
• Normally functioning hepatic gluconeogenetic and glycogenolytic 
system 
• Normal endocrine system for modulating these processes 
 This glucose generation and homeostatic process, partially explains 
the aetiology of hypoglycaemia in most of the infants. 
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GLUCONEOGENESIS 
 The fetus can carry out gluconeogenesis to a limited degree, although 
it is likely that under normal circumstances it does not need this function. 
The key gluconeogenetic enzymes namely Pyruvate dehydrogenase, 
pyruvate carboxylase, phosphoenolpyruvate carboxylase, pyruvate kinase, 
fructose 1,6 DiPhosphatase which are present in the fetal liver by 2-3 
months of gestation12,13, are the substrate for activation of endocrine system 
and their inhibition. Activities of these enzymes are believed to increase 
throughout gestation and the neonatal period. .  
 The regulatory influences of gluconeogenesis pathway are insulin and 
glucagon ratio, intracellular accumulation of precursors, concentration of 
acetyl coA, NAD/NAD+ ratio. Increase in the concentration of intra cellular 
acetyl co A and NAD/NAD+ ratio results in the conversion of fat and fatty 
acids into glucose. Gluconeogenesis is also indirectly stimulated by 
adrenaline.  
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FIGURE 1 :GLUCONEOGENESIS 
 
 
 Thus all appropriately grown newborns, including the very premature, 
probably have some degree of gluconeogenic capability. However the 
growth retarded neonate may have impaired gluconeogenic capability. 
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Hypoglycemia 
 Historically, hypogylcemia has been defined as a whole blood 
glucose concentration of < 1.7 mmol/L in term infants and <1.1mmol/L in 
preterm term neonates. More recently hypoglycaemia has been defined in 
term infants as 2.2 – 2.5 mmol/L after the first 24 hours of life.  
 In a retrospective study Lucas et al 14 found that premature infants 
with birth weight of less than 1.8kg with blood sugar less than 2.6 mmol/L 
where at increased risk of lower developmental scores, particularly when 
blood sugar values were below this figure in repeated occasions. Others 
have shown that a deterioration in neurological function (measured by 
evoked potential) occurred with blood sugars level < 2.6 mmol/L               
(Kohet al 15) .According to Heck and Even berg’s16  neonatal hypoglycaemia 
is defined as 
3-24 hours < 2.24mmol/l 
>24hrs < 2.5mmol/l17,18. 
 The concentration of plasma or whole blood glucose at which 
clinician should consider intervention is known as operational threshold19. 
 These studies  define normoglycemia in new borns as blood sugar 
levels of 2.6 mmol/L and above, but levels below this does not necessarily 
12 
 
indicate potentially damaging hypoglycaemia. The chemical definition of 
hypoglycaemia must take into account the methodology of glucose 
determination. Glucose concentration in whole blood is approximately 10-
15% lower than that in plasma. Delay in determination after blood sampling 
may result in glucose oxidation by erythrocytes causing falsely low values.  
Causes of hypoglycaemia 
 Hypoglycemia is caused either by diminished glucose supply or 
increased glucose consumption or a combination of both mechanisms. 
Because normoglycemia initially depends upon glycogenolysis and 
gluconeogenesis, infants in whom either a substrate is lacking or the 
metabolic pathway is impaired may develop hypoglycaemia. 
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CAUSES OF HYPOGLYCAEMIA IN NEONATES: 
Diminished production 
 Limited glycogen 
 SGA 
 Prematurity 
 Birth stress 
 Glycogen storage disorders 
Limited gluconeogenesis 
 SGA 
 Inborn errors of metabolism 
Carbohydrate  
 Galactosemia 
 Glycogen storage disorders 
 Fructose intolerance 
Amino acids 
 Maple syrup urine disease 
14 
 
 Propionic acidemia 
 Methyl melonicaciduria 
 Hereditary tyrosinemia 
 Glutaricacidemia type II 
                  Fatty acids 
 Defects in carnitine metabolism 
 Acyl co enzyme dehydrogenase defects                 
Increased glucose utilisation due to hyperinsulinism 
 IDM 
 Beckwith Wiedemann syndrome 
 Nesidioblastosis or pancreatic adenoma 
 Erythroblastosisfetalis 
 Exchange transfusion 
 Drugs: chlorpropamide, benzothiazides, sympathomimetics 
 Malpositioned UA catheter 
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Increased glucose utilisation without hyperinsulinism 
 Sepsis 
 Hypothermia 
 Polycythemia-Hyperviscosity syndrome 
 Congential cardiac malformations 
 LGA infants who are not IDM 
 Congenital hypopituitarism 
Neurohypogylcemia (Hypoglycorrhachia) 
Decreased glucose production 
Limited glycogen stores 
Premature:  
 The third trimester of pregnancy is an important period for hepatic 
glycogen deposition. An infant delivered prematurely without the benefit of 
part of or the entire third trimester will have limited hepatic glycogen stores. 
The greater the degree of prematurity, the less glycogen will be present.  
16 
 
 Small for gestational age(SGA) premature infants are at extremely 
high risk for development of hypoglycaemia because available nutrients 
during intrauterine life are used for growth, with little set aside for glycogen 
storage. For this reason, SGA premature infants have extremely limited 
glycogen stores. 
Perinatal stress:  
 Hypoxia, acidosis, and alterations in fetal blood pressure and flow can 
stimulate catecholamine secretion in utero, which in turn will mobilise 
hepatic glycogen stores. In addition, hypoxia increases the rate of anaerobic 
glycolysis, thereby accelerating glucose use. These events deplete fetal 
glycogen stores and place the infant at risk for hypoglycaemia after 
delivery. 
Glycogen storage disorders:  
 These involve inherited defects in the glycogen metabolic pathway. 
Some of these like Ia, I, VI may be associated with hypogylcemia20. 
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Limited Neoglucogenesis 
 Small for gestational age infants: In majority of SGA neonates, 
hypoglycemia is short lived and is caused due to inadequate glycogen 
stores, high brain: body mass ratio(with corresponding increase in glucose 
consumption), reduced fat stores. In about 1% infants, hypoglycaemia is 
prolonged and requires intravenous glucose therapy for several hours to 
days.  
Factorswhich may account for this include a failure of counter regulation 
(including delayed maturation of gluconeogenesis) and hyperinsulinism21,22. 
These SGA neonates have elevated plasma concentrations of gluconeogenic 
precursors, suggesting an inability to convert exogenous gluconeogenic 
precursors, such as alanine, to glucose. 
Increased glucose utilisation due to hyperinsulinism 
 A variety of disorders are associated with fetal and neonatal 
hyperinsulinism24. In some disorders, the mechanisms for heightened beta 
cell function are well understood, whereas in others, the pathogenesis 
unclear. In the former category are infants of diabetic mothers (IDM) and 
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infants with altered pancreatic islets caused by conditions such as 
nesidioblastosis and pancreatic adenoma.  
 Those for whom an etiology is not clear include infants with 
erythroblastosis and Beckwith Wiedemann syndrome. Infants who have 
erythroblastosisfetalis have increased levels of insulinand an increase in 
number of pancreatic beta cells. The mechanism for this development is 
unclear, but one possibility is that glutathione released from hemolysed red 
cells inactivates insulin in the circulation, which triggers more insulin 
secretion and upregulates the beta cells. The finding of a hypogylcemic 
indexwho is macrosomic and requires high rates of glucose infusion(10 to 
20 mg/kg body weight per minute) suggests a hyperinsulinemic state. 
Infant of diabetic mother(IDM): 
 IDM are at greater risk for development of hypoglycaemia as a result 
of the carryover of the fetal hyperinsulinemic state into neonatal life. They 
have elevated plasma insulin concentrations and release insulin briskly in 
response to glucose challenge.24 
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Malposition of umbilical artery catheter: 
 The tip of an umbilical artery catheter located at the level between the 
tenth thoracic and second lumbar vertebrae may result in glucose stimulated 
hyperinsulinism. Several infants have been reported in hypogylcemia was 
relived only the tip of the umbilical artery catheter was repositioned. It has 
been proposed that glucose from the malpositioned catheter flows into the 
celiac axis, thereby stimulating insulin secrtion. 
Increased glucose utilisation without hyperinsulinism 
Sepsis: 
 Sepsis in neonate is often heralded by hypoglycaemia or 
hyperglycemia. The mechanisms for this are not understood. Several studies 
have indicated rapid glucose disposal rates after intravenous challenge in 
septic term neonates. Although this suggests a hyperinsulinemic state, 
insulin secretion in these neonates was normal. These hyperglycemia and 
hypoglycemia that often precede the other signs of sepsis in premature 
infants may be catecholamine mediated. Hyperglycemia  is a presentation of  
neonatal sepsis in some cases25; hypoglycemia with sepsis should be 
considered an indicator of fulminating infection. Transient hypoglycaemia 
which occurs in sepsis usually resolves in few days. 
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Hypothermia: 
 Hypothermia induced hypoglycaemia is due to rapid depletion of 
energy stores secondary to rapid heat production mediated by increased 
availability of catecholamines. Tissue use of glucose might also be 
increased under these conditions.  
Polycythemia: 
 A negative correlation between plasma hematocrit and glucose 
concentration has been repeatedly reported. Though the exact pathogenesis 
is not known, it has been suggested that hyperviscosity possibly acts as an 
independent variable to depress plasma glucose concentration26. 
Congenital cardiac malformations: 
 Neonates with congenital cyanotic heart disease or congestive cardiac 
failure are noticed to have lower mean blood glucose concentration than that 
in healthy controls. Decreased glycogen stores secondary to chronic hypoxia 
may be a contributing factor, though the exact mechanism is unknown. 
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Neurohypoglycemia (Hypoglycorrhachia): 
 Glucose is transported across blood brain barrier via a carrier 
mediated diffusion process. At least five such membrane carrier proteins 
known as glucose transporters have been identified in various tissues. The 
transport protein that facilitates glucose transport across brain microvessels 
is termed as GLUT1 and has the same properties as the one transports 
glucose into red blood cells. Mutations of the genes coding for GLUT1 can 
lead to seizures due to low brain and cerebrospinal fluid glucose levels 
inspite of normal blood glucose levels. 
PERSISTENT HYPOGLYCEMIA: 
 Most hypoglycaemia will resolve in 2-3 days. In cases of intractable 
hypoglycaemia requiring glucose infusions rates higher than 12mg/kg/min 
or requiring intravenous glucose for more than seven days, rare causes 
should be considered and investigated 
 This involves sending simulataneousSamples of blood for insulin and 
glucose estimation. An insulin : glucose ratio of >0.4 is suggestive of 
hyperinsulinemia. If insulin level is normal for blood glucose level then 
other causes of persistent hypoglycaemia should be considered and 
appropriate samples sent. 
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CAUSES OF PERSISTENT HYPOGLYCEMIA AND THEIR 
RELEVANT INVESTIGATIONS: 
CAUSES                                       INVESTIGATIONS 
Congenital hypopituitarism         serum growth hormone,  
      cortisol 
Adrenal insufficiency                  serum cortisol 
Hyperinsulinemic states               Insulin : glucagon ratio >0.4 
      Insulin level >0.6 
      C peptide level >0.2mmol/l 
      Pro insulin level >5pmol/l 
Galactosemia    presence of non glucose reducing 
      substances in urine   
      Measurement of galactose 1  
      phosphate uridyltransferase 
Glycogen storage disorders       lactic acidosis   
      Hyperuricemia 
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Maple syrup urine disease          Normal serum ammonia 
      Positive urine for ketones 
      Quantitative analysis of plasma  
      amino acids        
      (increasedleucine,  isoleucine,  
      valine) 
Mitochondrial disorders              lactic acidosis 
 
 
 
 
 
 
 
 
 
 
24 
 
Symptoms of hypoglycemia 
 The clinical features of neonatal hypoglycaemia as in most neonatal 
disorders are non specific, so it is not possible to confidentially diagnose 
neonatal hypoglycaemia clinically. They are caused due to neuroglycopenia 
and may range from seizures to no symptom at all. 
 In addition careful attention should be given to underlying cause of 
hypoglycaemia, which may be suggested by characteristic physical features 
or other suggestive symptoms27. 
• Jitteriness  
• Tremors  
• Apnea 
• Cyanosis 
• Limpness/lethargy 
• Seizures 
• Abnormal crying 
• Irritability 
• Feeding difficulty 
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• Grunting/ tachypnea 
• Hypothermia 
• Hypotonia 
• Tachycardia 
 It is unusual for a newborn with hypoglycaemia to have a 
classical autonomic nervous system response, sweating, pallor, 
tachycardia as occurs in adults. A low blood sugar detected by stick 
test should be checked by a laboratory blood assay for glucose.   
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Blood glucose screening 
 The high risk neonates who warrant screening of blood glucose have 
been highlighted in the following table 
TABLE 2: HIGH RISK SITUATIONS REQUIRING BLOOD 
GLUCOSE ESTIMATION 
• Preterm infants 
• Small for gestational age infants (Birth weight <10th percentile) 
• Large for gestational age infants (Birth weight >90th percentile) 
• IDM 
• Infants with Rh-hemolytic disease 
• Infants born to mothers receiving terbutaline, propanolol, oral 
hypoglycaemic agents 
• Infants with growth retardation (i.e three or more loose skin folds in 
gluteal region, decreased subcutaneous fat, and head to chest 
circumference difference >3cm) 
• Sick neonate(Perinatal asphyxia, polycythemia, sepsis,shock) 
• Infant receiving total parenteral nutrition 
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TABLE 3 : SCHEDULE OF BLOOD GLUCOSE MONITORING 
Risk factor/Etiology Frequency 
Infant of diabetic mother 
 
 
Preterms / Small for gestational age 
Sick babies/ babies on Intravenous 
fluids/ TPN 
Cord blood, 1h,2h,3h,6h then 6 
hourly for 48 hours 
 
1h,2h,3h,6h then 6 hourly for 72 
hours 
6  hourly individualised 
 
EVALUATION 
Estimation of blood glucose  
Laboratory diagnosis: 
 This is the most accurate method of estimation of glucose. The most 
frequently used method for glucose determination in the laboratory is an 
automated analysis technique with glucose oxidase or commercial glucose 
oxidase immobilised electrode28. In this method Glucose is oxidised to 
glucuronic acid & H2O2 which is catalysed by glucose oxidase. The 
resulting concentration of H2O2 is determined by Peroxidase or a coloured 
O2 acceptor 29. 
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FIGURE 2 :GLUCOSE OXIDASE PEROXIDASE METHOD 
 
 
 Plasma or serum glucose concentrations are determined, and the 
results are very accurate. It is also important to consider the differences in 
glucose content of plasma and blood. 
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 Plasma glucose values are higher than those of whole blood by about 
14%; the difference may be greater at very low glucose values ( less than 
30mg/dl). Whole blood glucose content also varies in accordance with the 
hematocrit. Neonatal red blood cells contain high concentrations of 
glycolytic intermediates such as reduced glutathione therefore whole blood 
must be deproteinized with zinc hydroxide before analysis.  
 Capillary blood samples should be collected from a warm heel. Also, 
the samples should be immediately tested or kept on ice because the rate of 
in vitro glycolysis is increased in red blood cells at room temperature, and 
the whole blood glucose values may drop 15 to 20mg/dl per hour if the 
sample is allowed to stand at room temperature.  
Reductiometric methods:  
 The principle of this traditional method depends on the glucose 
reducing property.  eg: ferricyanide method. By this method, total reducing 
sugar concentration can be determined5. Reductiometric methods when 
compared with enzymatic methods, the detection of blood glucose by the 
latter is found to be accurate2. 
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Hexokinase method 
This method is more accurate and highly specific for blood glucose 
estimation 
FIGURE 3 : HEXOKINASE METHOD 
 
 In this method, the NADPH/H+ yielded by the phosphorylation of 
glusose, which is catalysed by hexokinase is determined using suitable 
spectrophotometric analysis30. 
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Reagent strips: 
 This involves whole blood glucose concentration estimation using 
glucose oxidase and peroxidase chromogen test strip either alone or with a 
reflectance colorimeter. Though widely use , they are unreliable especially 
at blood glucose values < 40 – 50 mg/dl31-35.  
 They are useful for screening purposes and a low value obtained on 
them should always be confirmed by laboratory estimation. However a 
concurrent treatment should be instituted while awaiting a laboratory 
confirmation36. 
 If the sample viscosity is higher it may interfere with the diffusion of 
the plasma into the strip, so in order to overcome this, heparinised micro 
hematocrit tube is used37. Some of the commercially available paper strips 
are dextrostix, Chemstrip, BM test Glycemia38, 39, 40. 
Glucose electrode system: 
 This system uses electrode based analyser for measuring the level of 
glucose in the plasma using 25µL sample of uncentrifuged blood. This 
method is mostly used by nurses in clinical settings41.  
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 The linear correlation between this method and laboratory glucose 
oxidase peroxidase methodis good between the concentration0 to 100 
mg/dL. The main advantage of this method is that the assay is not affected 
by the sample hematocrit and bilirubin42. This method is costly compared 
with other reflectance meters. 
Other bedside systems 
Hemocue glucose photometer: 
When compared to reagent strip or electrode methods, the cost is high in 
HemoCue. Room temperature variation and cuvette storage temperature will 
produce many errors, even though they are more useful when glucose 
concentration is higher.  
 A recent study in Nepal43  showed that this method is not suitable for 
the detection of hypoglycaemia(<2mmol/L) since it over estimated the 
neonatal blood glucose concentrations. 
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FIGURE 4: HEMOCUE PHOTOMETER FOR GLUCOSE 
ESTIMATION 
 
MANAGEMENT OF HYPOGLYCEMIA: 
 The occurrence of hypoglycaemia should prompt consideration of the 
cause. It is particularly important to note that term breastfed babies do not 
develop symptomatic hypoglycaemia as a result of simple underfeeding. 
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Presence of hypoglycaemia in this group is likely to be a manifestation of 
underlying illness, for example sepsis. Detection and treatment of the cause 
is as important as correction of the blood glucose concentration. 
Healthy Asymptomatic Infants 
 It has been suggested that as many as 10 % of the healthy infants who 
are the appropriate size for gestational age develop transient asymptomatic 
hypoglycaemia, which in most cases is managed by the initiation of early 
feeding.  
 This type of hypoglycaemia is often transient and recovers 
spontaneously. However, in clinical practice it is often treated with early 
feedings. Controlled studies examining the benefits or impact of this early 
feeding on recovery from hypoglycaemia have not been performed.  
 Direct breast feeding is the best option among early feed initiation. If 
the baby is unable to suck, expressed breast milk may be used. If breast milk 
is not available, then formula milk may be given. Such a supplementation 
may be tried in infants for whom blood glucose is 20 – 40 mg/dl and who 
are otherwise asymptomatic. 
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SYMPTOMATIC INFANTS / VERY LOW GLUCOSE 
CONCNETRATION IN ASYMPTOMATIC INFANTS 
 Symptomatic babies should be treated with parenteral glucose 
infusion. Also, the infants who have blood glucose concentration <20mg/dl 
should be managed with intravenous glucose. These infants should be 
administered a mini bolus of 200mg/kg glucose as 2ml/kg of 10% dextrose 
over 1 minute. This should be immediately followed by an infusion of 10% 
dextrose at a rate of 6mg/kg/min. 
 Subsequently, blood glucose should be checked after 30 minutes, and 
if it has normalised (>50mg%), then infusion should be continued at the 
same rate and blood glucose monitored 6th hourly. If the blood glucose 
continues to be low, increase infusion rate by 2mg/kg/min every 30 minutes 
to a maximum of 12mg/kg/min. 
 If two or more blood glucose values are >50mg/dl after 24 hours of 
parenteral glucose and the primary underlying condition has been taken care 
of, and there is no contraindication to enteral feeds, the baby should be 
initiated on oral feeds. Simultaneously, the glucose infusion can be tapered 
by 2mg/kg/min every 6 hours. Once the infusion rate is 4mg/kg/min, and 
oral intake is adequate, the parenteral glucose infusion can be stopped. 
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 The intravenous infusion of the glucose should never be stopped 
abruptly; it leads to severe rebound hypoglycaemia. Also, infusion of 
glucose concentration >12.5% in a peripheral vein may lead to 
thrombophlebitis and hence a central venous catheter should be inserted if 
glucose concentration >12.5% is required. In addition, while increasing the 
glucose infusion rate one should also ensure that the baby does not go into 
fluid overload. 
MANAGEMENT OF PERSISTENT HYPOGLYCEMIA 
   In cases of intractable hypoglycaemia, after sending the requisite 
investigations, central venous line maybe inserted to enable infusion of 
higher concentration and higher rates of glucose. Besides increase in 
glucose infusion, following drugs may also be tried in refractory cases. 
• HYDROCORTISONE: 
  5 – 15 mg/kg/day intravenously in two divided doses. It is most 
useful in hypoglycaemia due to adrenal insufficiency and rarely used 
nowadays for other indications. 
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• DIAZOXIDE 
  10 – 25mg/kg/day per orally in three divided doses for 
treatment of hypoglycaemia due to hyperinsulinism. It acts by reducing 
insulin secretion and increasing catecholamine release. It can be used for 
prolonged periods without any significant side effects. 
• GLUCAGON 
  30 -300 mcg/kg/dose intravenous, intramuscular or 
subcutaneously. It can be used to increase blood glucose levels in acute 
situations before intravenous glucose infusion can be started. It acts by 
increasing both glycogenolysis and gluconeogenesis. However the effect is 
short lasting and glucose infusion is required to maintain blood glucose 
levels for a longer period. It should not be used in SGA infants who are 
normally glycogen depleted. 
• OCTREOTIDE 
  5-10mcg/kg subcutaneously, Every 6 to 8 hourly. It  suppresses 
the secretion of various hormones including insulin. 
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MATERIALS AND METHODS 
STUDY DESIGN 
 This is an analytical cross sectional study . 
STUDY SETTING 
 Neonatal intensive care unit, Government Rajah Mirasdar Hospital, 
Thanjavur Medical College,Thanjavur. 
STUDY POPULATION 
 200 Newborns admitted in NICU,Government Rajah Mirasdar 
Hospital, Thanjavur Medical College during the period of 6 months from 
January 2016 to July 2016. 
INCLUSION CRITERIA :  
• Neonates admitted in Neonatal Intensive Care Unit Level 3, 
Department of Paediatrics, Thanjavur Medical College Thanjavur.   
EXCLUSION CRITERIA   :   
• Infants >28 days.  
• Neonates with PCV less than 40% and more than 65%     
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SAMPLING PROCEDURE 
 Consecutive sampling 
SAMPLE SIZE 
 200 neonates admitted in Neonatal Intensive Care unit, Government 
Rajah Mirasdar Hospital during the period of 6 months from January 2016 
to July 2016 
TOOLS 
 1. Glucose oxidase peroxidase method 
Principle:  
 The β D glucose present in the plasma is acted upon by the glucose 
oxidase enzyme to produce hydrogen peroxide. This in turn is acted upon by 
peroxidase enzyme to produce water and oxygen. This oxygen reacts with 
oxygen acceptor like ortho toluidine to produce a coloured product that is 
estimated by calorimeters. 
2. Glucometer(ACCU CHECK ACTIVE/Sensor glucometer) 
 Meter type - ACCU-CHEK Active Meter Measuring range- 10-600 
mg/dL Sample size - 1µL Measuring time - Approximately 5 seconds 
Samples: venous, arterial, finger stick capillary. 
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Principle:  
 The test strip containing glucose dehydrogenase catalyzes a selective 
electron-transfer reaction between glucose in the sample and potassium 
ferricyanide in the reagent layer. Each molecule of glucose reduces two 
molecules of ferricyanide, creating two molecules of ferrocyanide.The final 
ferrocyanide concentration is directly correlated to the sample glucose 
concentration. 
Procedure: 
 Hold the test strip so the arrows printed on it and the orange square 
faces upwards and push it into the machine. After heel prick with lancet, 
apply a drop of blood to the centre of the orange field. An hourglass 
indicates the test is in progress. The test is complete after approximately 5 
seconds and results appears on the display. 
DATA COLLECTION PROCEDURE 
Antenatal History: 
 History regarding regular antenatal checkups was enquired. History 
of medical illness like diabetes, fever during first trimester or third trimester 
was asked. History of obstetric complications like PIH, eclampsia, 
antepartum hemorrhage, oligo or polyhydramnios was noted. 
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Perinatal History:  
 History of Premature rupture of membranes, prolonged second stage 
of labour, Meconium staining of liquor, place of delivery, type of delivery 
and indication for forceps and caesarean section was noted. After delivery 
whether baby cried immediately or not, was it meconium stained and any 
resuscitation done was noted. Apgar score at 1minute and 5minutes of birth 
was documented in inborns and if mentioned in the referral was noted in the 
outborns.  
Sample collection  
 After washing hands,the infant’s heel is held with a moderately firm 
grip. The forefinger is placed at the arch of the foot and the thumb below the 
puncture site at the ankle.After selection of the puncture site, (the ideal site 
being lateral/medial edges of the plantar surface-to avoid damage to 
calcaneus),the area is cleaned with warm water & gauze. 
 The sites punctured using a lancet with a quick controlled stroke.The 
first drop of blood is wiped off with a cotton ball or gauze and discarded as  
it may be contaminated with skin cells, alcohol or excess tissue fluid, which 
may distort test results. The heel is held in a dependent position and gentle 
pressure applied to facilitate blood flow. Excessive squeezing of the heel 
may cause haemolysis or contamination of the specimen from interstitial 
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fluid leakage & bruising.Gentle pressure with a cotton ball or gauze is 
applied,once adequate blood volume has been collected,until bleeding stops. 
 
 Then 2 ml of blood drawn from the peripheral vein was used for 
estimating the glucose levelin the laboratory by glucose oxidase 
method.Blood from the sample was used to estimate the venous blood 
glucose level by glucometer.Complete blood count was also done for PCV 
estimation with the sample collected from peripheral vein. 
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Examination 
 The venous blood glucose was estimated by the glucometer and in the 
laboratory by the glucose oxidase peroxidase method. Estimation of the 
capillary blood glucose level by glucometer was also done. Values obtained 
by laboratory glucose oxidase method were taken as the gold standard. The 
samples were collected in the newborn babies who were admitted in NICU 
level 3.Pearson correlation was used for the statistical analysis. 
INVESTIGATIONS   
1. Blood glucose level using glucometer Accu-check (venous 
sample) 
2. Blood glucose level using glucose oxidase peroxidase method 
in the laboratory (venous sample) 
3. Blood glucose level using glucometer (capillary sample by heel 
prick method) 
4. Complete blood count.(For PCV estimation) 
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DATA ANALYSIS 
Analysis of Cases and Results:  
 200 neonates who were admitted to NICU level 3, RAJAH 
MIRASDAR HOSPITAL, THANJAVUR MEDICAL COLLEGE, 
THANJAVUR, during the period of 6 months from January 2016 to July 
2016. 
Sex Distribution: 
TABLE 4: DISTRIBUTION OF CASES ACCORDING TO SEX 
 
Sex 
No.of cases 
(n=200) 
Percentage 
(100%) 
Male 118 59.0 
Female 82 41.0 
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In our study, 118 (59%)cases were male babies and 82(41%) cases were 
female babies with the male to female ratio of 1.4:1. 
 
FIGURE 5: DISTRIBUTION OF CASES ACCORDING TO SEX 
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Out of 31 cases of hypoglycaemia detected by glucose oxidase 
peroxidase method in the laboratory using venous blood, 20(64.5%) were 
males and 11(35.5%) were female neonates. 
FIGURE 6 :DISTRIBUTION OF HYPOGLYCEMIA CASES 
ACCORDING TO SEX 
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GESTATIONAL AGE: 
TABLE 5:DISTRIBUTION OF CASES IN RELATION TO 
GESTATIONAL AGE 
 
In the present study of the 200 babies, 120 were full term (60%) and 
80((40%) were preterm neonates. 
 
 
 
 
 
Gesttional age 
No.of cases 
(n=200) 
Percentage 
(100%) 
Preterm 80 40.0 
Term 120 60.0 
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FIGURE 7: DISTRIBUTION OF CASES IN RELATION TO 
GESTATIONAL AGE 
 
 
 
 Of the 31 cases of hypoglycaemia detected by glucose oxidase 
peroxidase method in the laboratory using venous blood, 16 (51.6%) were 
preterm and 15(48.4%) were term neonates. 
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FIGURE 8: DISTRIBUTION OF HYPOGLYCEMIA CASES                    
IN  RELATION TO GESTATIONAL AGE 
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PLACE OF DELIVERY: 
TABLE 6: DISTRIBUTION OF CASES IN RELATION TO 
PLACE OF DELIVERY 
 
Place of delivery 
No.of cases 
(n=200) 
Percentage 
(100%) 
Outborn 61 30.5 
inborn 139 69.5 
 
Of the 200 cases studied, 61(30.5%) were outborn and 139 (69.5%) 
were inborn. 
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FIGURE 9: DISTRIBUTION OF CASES IN RELATION  TO 
PLACE OF DELIVERY 
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FIGURE 10: DISTRIBUTION OF HYPOGLYCEMIA CASES 
IN RELATION  TO PLACE OF DELIVERY 
 
 
 
Of the 31 cases of hypoglycaemia detected by glucose oxidase 
peroxidase method in the laboratory using venous blood, 13(41.9%) were 
outborn, and 18(58.1%) were inborn neonates. 
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MECHANICAL VENTILATION: 
TABLE 7: DISTRIBUTION OF CASES IN RELATION TO 
MECHANICAL VENTILATION 
 
Mechanical ventilation 
No.of Cases 
(n=200) 
Percentage 
(100%) 
Yes 34 17.0 
No 166 83.0 
 
 In our study of the 200 cases,34 cases(17%) were mechanically 
ventilated and 166 cases(83%) did not require mechanical ventilation. 
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FIGURE 11: DISTRIBUTION OF CASES IN RELATION  TO 
MECHANICAL VENTILATION 
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Of the 31 cases of hypoglycaemia detected by glucose oxidase 
peroxidase method in the laboratory using venous blood, 26(83.9%) cases 
were not ventilated and 5(16.1%) were ventilated. 
 
FIGURE 12: DISTRIBUTION OF HYPOGLYCEMIA IN 
VENTILATED AND NON VENTILATED CASES 
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GLUCOSE OXIDASE METHOD 
TABLE 8: DISTRIBUTION OF CASES ACCORDING TOLAB 
VALUES BY GLUCOSE OXIDASE PEROXIDASE METHOD 
 
 
 
 
 
 
 
 In our study,of the 200 cases,blood glucose values were less than or 
equal to 40mg/dl in 31 cases (15.5%), between 41-150mg/dl in 164 (82%) 
cases and above 151mg/dl in 5 cases(2.5%)  by glucose oxidase peroxidase 
method. 
 
 
 
Lab values 
(mg/dl) 
No. of cases 
(n=200) 
Percentage 
(100%) 
Below 40 31 15.5 
41 to 150 164 82.0 
Above 151 5 2.5 
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FIGURE 13: DISTRIBUTION OF CASES ACCORDING TOLAB 
VALUES BY GLUCOSE OXIDASE PEROXIDASE METHOD 
 
 
 Glucose oxidase peroxidase method was taken as gold standard in this 
study. 
 
 
0
10
20
30
40
50
60
70
80
90
Below 40 41 to 150 Above 151
15.5
82
2.5
PE
RC
EN
TA
G
E
58 
 
CAPILLARY ESTIMATION OF BLOOD GLUCOSE 
BYGLUCOMETER 
 In our study, of the 200 cases,26 cases (13%) had blood glucose 
values less than or equal to 40mg/dl, 164 (82%) had blood glucose values of 
41-150mg/dl.10 cases (5%) had blood glucose values above 151mg/dl, 
when capillary blood glucose was estimated using glucometer. Of the 31 
cases of hypoglycaemia detected by laboratory method, 23 cases of 
hypoglycaemia (less than or equal to 40mg/dl) were detected by capillary 
blood glucose method. 
TABLE 9: DISTRIBUTION OF CASES ACCORDING TO 
CAPILLARY BLOOD GLUCOSE BY GLUCOMETER 
Values (mg/dl) 
No.ofcases 
(n=200) 
Percentage 
(100%) 
Below 40 26 13.0 
41 to 150 164 82.0 
Above 151 10 5.0 
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FIGURE 14:  DISTRIBUTION OF CASES ACCORDING TO 
CAPILLARY BLOOD GLUCOSE BY GLUCOMETER 
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VENOUS BLOOD GLUCOSE ESTIMATION BY GLUCOMETER 
 In our study, of the 200 cases, 32 cases (16%) had blood glucose 
values less than or equal to 40mg/dl ,161 (80.5%) had blood glucose values 
of  41-150mg/dl. 7 cases(3.5%) had blood glucose values above 151mg/dl, 
when venous blood glucose was estimated using glucometer. 
TABLE 10: DISTRIBUTION OF CASES ACCORDING TO VENOUS 
BLOOD GLUCOSE BY GLUCOMETER 
 
Values(mg/dl) 
No. ofcases 
(n=200) 
Percentage 
(100%) 
Below 40 32 16.0 
41 to 150 161 80.5 
Above 151 7 3.5 
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FIGURE 15:DISTRIBUTION OF CASES ACCORDING TO VENOUS 
BLOOD GLUCOSE BY GLUCOMETER
 
 
 Of the 31 cases of hypoglycaemia detected by lab method, 29 cases of 
hypoglycaemia (less than or equal to 40mg/dl) were detected by venous 
blood glucose method. 
Below 40, 16
41 to 150, 80.5
Above 151, 3.5
Below 40 41 to 150
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TABLE 11: DIAGNOSTIC VALUE OF CAPILLARY BLOOD 
GLUCOSE ESTIMATION BY GLUCOMETER IN COMPARISION 
TO LAB VALUE IN DETECTING THE HYPOGLYCEMIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VALUE PERCENTAGE 
True Positive (a) 23 
True Negative (d) 166 
False Positive (b) 3 
False Negative (c) 8 
Sensitivity 74.19 
Specificity 98.2 
PPV 88.4 
NPV 95.4 
ACCURACY 94.5 
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Sensitivity = a/a+c = 74.19% 
Specificity = d / b+d = 98.2% 
PPV = a / a+b = 88.46% 
NPV = d / c+d = 95.4% 
Accuracy = a+d /a+b+c+d  = 94.5 
 Capillary blood glucose monitored by glucometer has sensitivity of 
74.19% and specificity of 98.2% , positive predictive value of 88.4% , 
negative predictive value of 95.4% and accuracy of 94.5% with statistically 
a significant P value< 0.05 
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TABLE 12: DIAGNOSTIC VALUE OF VENOUS BLOOD GLUCOSE 
ESTIMATION BY GLUCOMETER IN COMPARISION TO LAB 
VALUE IN DETECTING THE HYPOGLYCEMIA 
VALUE PERCENTAGE 
True Positive (a) 29 
True Negative(d) 166 
False Positive(b) 3 
False Negative(c) 2 
Sensitivity 93.55 
Specificity 98.23 
PPV 90.62 
NPV 98.8 
ACCURACY 97.5% 
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Sensitivity = a/a+c = 93.55% 
Specificity = d / b+d = 98.23% 
PPV = a / a+b = 90.62%  
NPV = d / c+d = 98.8% 
Accuracy = a+d / a+b+c+d = 97.5% 
 Venous blood glucose monitored by glucometer has sensitivity of 
93.55% and specificity of 98.23% , positive predictive value of 90.62% , 
negative predictive value of 98.8% and accuracy of 97.5% with statistically 
a significant P value < 0.05. 
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EXPECTED OUTCOMES 
DISCUSSION 
 In the present study, 200 neonates admitted in level 3 NICU were 
studied for a period of 6 months. Both intramurally and extramurally 
delivered babies were included in this study. 
 In our study, we evaluated the efficacy of glucometer as a good 
screening tool in estimating the blood glucose level in newborn (both 
capillary and venous) in comparison with laboratory glucose oxidase 
peroxidase method. The study was also used to determine the sensitivity, 
specificity, predictive value and accuracy of glucometer compared to 
glucose oxidase peroxidase method. 
 Laboratory glucose oxidase peroxidase method of blood glucose 
estimation was taken as gold standard. 
 In this prospective study, 200 neonates were studied with varied 
symptomatology. Of these, 59% of the cases were male babies, 41% of the 
cases were female babies.Of the 200 babies, 40% babies were born preterm 
and 60% babies were term. 
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 Hypoglycaemia was defined as blood glucose level less than 40 
mg/dl3. 
 In this study, out of 200 babies, 31 babies (15.5%) were found to be 
hypoglycaemic by laboratory glucose oxidase peroxidase method which is 
comparable with previous studies by PK SINGHAL et al44& PK MISHRA 
& BINA SHARMA 45where the incidencewas 4.8% & 9.7% in their studies 
respectively. 
 This basal variation in the incidence of hypoglycaemia could be 
attributed to the lack of uniform definition of hypoglycaemia, variable 
sample size and multiple risk factors.  
 In the PK SINGHAL et al44 study hypoglycaemia was defined as 
blood glucose level less than 30mg% while in the PK MISHRA AND BINA 
SHARMA45  study it was taken as 20mg% 
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COMPARISON OF OVERALL INCIDENCE OF HYPOGLYCEMIA 
WITH OTHER STUDIES 
 
 
 
 
 
 
 Hypoglycaemia detected by capillary blood glucose and venous blood 
glucose using glucometer was 23 cases (11.5%) and 29 cases (14.5%) 
respectively which was in concordance with laboratory oxidase peroxidase 
method which detected 31 cases(15.5%) of hypoglycaemia in our study 
population. This is comparable with previous study HAMID mhet Al46 
which   detected hypoglycaemia by laboratory method in 11% and by 
capillary blood glucose method in 11% cases. 
 
 
STUDIES INCIDENCE 
PK SINGHAL et al44 4.8% 
PK MISHRA & BINA SHARMA45 9.7% 
OUR STUDY 15.5% 
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 In our study, euglycaemia detection by glucose oxidase peroxidase 
method were 164 cases (82%) while glucometer detected euglycaemia by 
Capillary blood glucose method in 156 cases( 78%) and by venous blood 
glucose method in 158 cases(79%) which is in concordance with glucose 
oxidase method. 
 Capillary blood glucose estimated by glucometer has sensitivity of 
74.19% and specificity of 98.2% , positive predictive value of 88.4% , 
negative predictive value of 95.4% and accuracy of 94.5% and a statistically 
significantP  value < 0.05.  
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COMPARISON OF SENSITIVITY AND SPECIFICITY OF THE 
ESTIMATION OF CAPILLARY BLOOD GLUCOSE BY 
GLUCOMETER WITH OTHER STUDIES 
STUDIES SENSITIVITY SPECIFICITY 
Dahlberg et al 47 100% 84% 
Mehta et al48 86% 89% 
H O Ht et al 49 92.3%  
M Ellis et al 50 83% 62% 
Hamid MH et al46 98% 63% 
Our study 74.19% 98.2% 
 
 Venous blood glucose monitored by glucometer has sensitivity of 
93.55% and specificity of 98.23%, positive predictive value of 90.62% , 
negative predictive value of 98.8% and accuracy of  97.5% with a 
statistically significant P value < 0.05. 
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 These figures indicate that measuring Capillary blood glucose and 
venous blood glucose using glucometer is a reliable tool to diagnose 
neonatal hypoglycaemia. Further blood glucose estimated by glucometer 
using venous bloodwas more sensitive than capillary blood. 
 Moreover, capillary blood glucose monitoring by glucometer has the 
added advantages as follows: 
          Quick performance within few minutes  
          Least required preparation 
          No risk for the patient 
Cheaper and cost effective. 
Less blood to be drawn 
Less trauma to baby 
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SUMMARY 
• In our study, of the 200 neonates118 (59%) cases were male and 
82(41%) cases were female with the male to female ratio of 1.4:1. 
Out of 31 cases of hypoglycaemia detected by glucose oxidase 
peroxidase method in the laboratory using venous blood, 20(64.5%) 
were males and 11(35.5%) were female neonates. 
• In the present study of the 200 babies, 120were term (60%) and 
80(40%) were preterm.Of the 31 cases of hypoglycaemiadetected by 
glucose oxidase peroxidase method in the laboratory using venous 
blood 16 (51.6%) were preterm and 15(48.4%) were term neonates. 
• Of the 200 cases studied, 61(30.5%) were outborn and 139 (69.5%) 
were inborn.Of the 31 cases of hypoglycaemia detected by glucose 
oxidase peroxidase method in the laboratory using venous blood, 
13(41.9%) were outborn, and 18(58.1%) were inborn neonates. 
• In our study, of the 200 cases, 34 cases (17%) were mechanically 
ventilated and 166 cases (83%) did not require mechanical 
ventilation.Of the 31 cases of hypoglycaemia detected by glucose 
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oxidase peroxidase method in the laboratory using venous blood, 
26(83.9%) cases were not ventilated and 5(16.1%) were ventilated. 
• In our study, of the 200 cases ,31 cases (15.5%) were hypoglycaemic,  
164(82%)cases were euglycemic and 5 cases (2.5%) were 
hyperglycemic by laboratory glucose oxidase peroxidase method, 
which is taken as the gold standard. 
• Capillary Blood glucose estimation using glucometer detected 23 
cases (74.2%) of hypoglycaemia, 156 cases (95.1%) of 
euglycemiaand  5 cases (100%) of hyperglycemia in comparison with 
laboratory glucose oxidase peroxidase method. 
• Venous blood glucose estimation using glucometer detected 29 cases 
(93.5%) of hypoglycaemic, 158 cases (96.3%) of euglycemia and 3 
cases (60%) of hyperglycemia in comparison with laboratory glucose 
oxidase peroxidase method. 
• Estimation of capillary blood glucose by glucometer was found to 
have a sensitivity of 74.19% , specificity of 98.2 % , positive 
predictive value of 88.4% , negative predictive value of 95.4% and 
accuracy of  94.5% with statistically significant P  value < 0.05 
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• Estimation of venous blood glucose using glucometer was found to 
have a sensitivity of 93.55% , specificity of 98.23 % , positive 
predictive value of 90.62%  negative predictive value of 98.8% and 
accuracy of 97.5% with statistically significant P value < 0.05. 
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CONCLUSION 
1. Estimation of blood glucose using capillary and venous blood using 
glucometer have  strong  correlation with laboratory oxidase 
peroxidase method in detecting neonatal hypoglycaemia. 
2. The sensitivity of detecting neonatal hypoglycemia by glucometer 
using venous blood is higher than capillary blood. 
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 PROFORMA 
BABY OF      :             
DOA       : 
IP NO.      : 
BIRTH WEIGHT     : 
GESTATIONAL AGE     : 
DAY OF LIFE     : 
SEX       : 
MODE OF DELIVERY    : 
DATE AND TIME OF BIRTH   :    
PLACE OF BIRTH    : 
MATERNAL COMPLICATIONS  : 
APGAR SCORE AT 1ST MINUTE  : 
                                5TH MINUTE  : 
INTRAMURAL/EXTRAMURAL  : 
CRIED SOON AFTER BIRTH/NOT  : 
INDICATION FOR NICU ADMISSION : 
ON MECHANICAL VENTILATION/NOT: 
 
INVESTIGATIONS: 
BLOOD GLUCOSE 
LEVEL BY 
LABORATORY 
GLUCOSE 
OXIDASE 
METHOD 
GLUCOMETER 
(ACCU-CHECK 
ACTIVE) VENOUS 
SAMPLING 
GLUCOMETER 
(ACCU-CHECK 
ACTIVE) 
CAPILLARY 
SAMPLING 
   
   
 
 
 
S.NO IP NO B WT (kg) G.A SEX D.O.L M.O.D P.O.B D.O.B MAT COMP APGAR IM/EM
CR AFT 
BIRTH IND NICU ADM M.V
CBG 
(mg/dl)
VBG(m
g/dl)
LAB 
(mg/dl)
1 427653 2.5 38 f 1 lscs mannarkudi gh 15,6 cpd na,na EM yes resp distress of 
nb no 92 84 78
2 427382 2.75 37 f 1 forceps rmh 14.6. cpd 7,8 im yes resp dist/erbs no 86 92 108
3 424968 3 39 m 3 lscs puthukottai gh 10.6. failed induction na,na EM yes resp distress of 
nb no 106 98 84
4 427831 3 39 m 1 lscs rmh 17.6 gdm 7,8 im yes idm no 74 68 54
5 407907 1.9 32 m 1 lscs rmh 17.6. oligohydramino
s
4,8 im yes rds/pt/lbw no 114 106 118
6 427617 2.5 30 m 1 lscs rmh 15.6. prom 2,5 im yes birth asphyxia no 114 92 68
7 424679 2.7 38 m 3 lscs rmh 09.6. pih na,na im no sepsis no 112 90 76
8 427968 3 38 m 1 lscs jeyamkon gh 16.6. prev lscs 7,8 EM yes resp distress of 
nb no 86 70 58
9 427761 3 39 m 1 nvd puthukottai gh 18.6. nil 7,8 EM yes resp distress of 
nb no 140 132 112
10 427888 3 39 m 1 lscs rmh 18.6 nil 5,8 im yes hydrocephalus no 136 120 98
11 427761 2.8 38 f 1 nvd rmh 16.6 nil 3,7 im yes sepsis no 118 124 104
12 428823 2.6 41 m 1 nvd rmh 23.6 nil na,na im no birth asphyxia no 76 82 94
13 427497 1 28 f 8 nvd rmh 15,6 nil 4,7 im yes rds/pt/lbw no 172 160 132
14 427490 2.8 38 m 1 lscs rmh 23,4 pih 4,8 im yes sepsis yes 72 68 54
15 427242 1.3 41 m 1 lscs puthukottai gh 14.6 pih 4,7 EM yes iugr/lbw/resp dis no 34 32 32
16 418653 1.4 30 f 1 nvd rmh 24.4 idm na,na im yes rds/pt/lbw no 86 72 50
17 417539 2.7 38 f 1 nvd rmh 25,4 anemia na,na im no birth asphyxia no 92 88 76
18 423924 2.8 40 m 1 nvd rmh 31,5 nil 7,8 im yes resp distress of 
nb no 88 60 75
19 416927 2.8 40 m 3 nvd rmh 22.6 nil 8,8 im yes sepsis no 43 42 44
20 423397 2.96 40 m 1 lscs pvt hos 31,5 prom 4,6 EM no birth asphyxia no 102 90 75
21 423956 2.5 38 m 2 nvd sirkali gh 4,6 chd 7,8 EM yes meningomyeoce
e
no 86 72 60
22 423751 2.9 41 f 1 lscs rmh 3,6 cord prolapse 3,5 im no birth asphyxia no 34 44 53
23 418145 3.5 39 m 2 lscs puthukottai gh 24,5 gdm 6,7 EM yes a.v 
malform/sepsis no 80 72 65
24 418362 1 30 m 1 nvd rmh 25,5 prom 8,9 im yes rds/pt/lbw yes 96 82 60
25 418962 2.5 37 m 4 lscs rmh 25,4 nil 6, im yes sepsis no 47 38 24
26 423519 2.9 40 m 18 lscs rmh 16,5 cpd 7,8 im yes sepsis yes 98 90 70
27 423529 1.75 32 m 1 nvd rmh 2,6 nil 8,9 im yes rds/pt/lbw no 134 110 120
28 423680 2.5 37 m 1 nvd rmh 4,6 pih 3,6 im no birth asphyxia no 94 78 65
29 423245 1.4 34 m 5 lscs rmh 17,5 pih 7,8 im yes rds/pt/lbw yes 94 82 68
30 421624 2.1 37 m 1 lscs rmh 21,5 idm 8,8 im yes sepsis no 88 64 72
31 418760 4.6 38 m 1 lscs rmh 29,4 idm 8,8 im yes idm no 60 82 67
32 418458 1.1 30 m 1 nvd rmh 30,4 nil 6,8 im yes rds/pt/lbw yes 90 72 66
33 421029 1.41 31 m 1 nvd rmh 17,5 nil 6,7 im yes rds/pt/lbw no 362 388 342
34 428849 1.5 32 f 1 lscs rmh 23,6 pih 6,8 im yes lbw no 84 102 90
35 485699 2.7 39 m 4 nvd rmh 2,6 nil 5,8 im yes sepsis no 94 88 71
36 422845 2.3 40 f 2 nvd patukot gh 26,5 anemia 5,7 EM yes sepsis no 36 40 36
37 424125 1.25 32 m 28 nvd manarkudi gh 8,5 anemia 7,8 EM yes rds/pt/lbw no 104 92 71
38 423258 2.1 36 f 2 nvd rmh 31,5 pih 7,9 im yes iugr/lbw/resp dis no 40 32 21
39 421567 1.7 32 m 3 nvd rmh 17.6.16 nil 8,9 im yes sepsis no 84 78 56
40 423883 1.65 32 f 8 lscs rmh 28,5 pih 8,9 im yes rds/pt/lbw no 94 80 72
41 428902 3.6 40 f 4 nvd outborn 20.6.16 nil 6,9 EM no sepsis no 32 66 48
42 421901 1.75 34 f 1 lscs rmh 24,6 twin 6,9 im yes rds/pt/lbw no 100 94 72
43 421901 3 38 f 1 nvd rmh 23,5 prom 4,6 im no birth asphyxia yes 94 88 76
44 428870 3.1 39 m 1 lscs rmh 23,6 gdm 7,8 im yes idm no 28 35 24
45 428486 2.6 37 m 1 lscs rmh 20,6 nil 7,8 im yes msaf/resp dist no 168 162 146
46 428824 2.1 35 f 1 nvd rmh 23,6 hypothyroid 6,8 im yes resp distress of 
nb yes 140 134 122
47 428160 2.4 38 m 4 nvd rmh 19,6 nil 6,8 im yes sepsis 104 96 84
48 427953 3 40 m 1 lscs rmh 18,6 gdm 8,9 im yes idm no 82 70 58
49 427862 3.7 39 f 1 nvd rmh 17,6 nil 5,7 im yes chd yes 124 110 92
50 427930 3 39 m 7 lscs rmh 16,6 prev lscs 4,8 im yes sepsis no 124 110 94
51 428904 2.6 38 f 1 lscs rmh 23,6 nil 6,9 im yes resp distress of 
nb no 152 146 136
52 427168 2.8 37 m 6 nvd rmh 13,6 nil 7,8 im yes sepsis no 92 84 72
53 428634 2.75 38 f 2 lscs rmh 21,6 oligohydramino
s
8,8 im yes sepsis no 142 134 126
54 427467 2.1 36 m 3 lscs rmh 14,6 oligohydramino
s
8,9 im yes seizures no 170 146 174
55 424593 2.4 37 f 2 nvd thiruvarur gh 8,6 nil 4,6 EM no birth asphyxia no 144 132 120
56 429003 2.6 38 m 1 nvd rmh 24,6 nil 8,9 im yes resp distress of 
nb yes 122 102 94
57 428630 3 38 m 1 nvd rmh 24,6 hypothyroid 7,8 im yes sepsis 110 92 106
58 429020 1.75 34 m 1 nvd rmh 24,6 nil 7,8 im yes lbw/resp distress 106 134 112
59 412679 1.8 39 m 2 nvd rmh 17.3 nil 6,7 im yes anomalous baby yes 86 92 46
60 413438 3.15 39 m 1 nvd pvt hos 20.3 nil 8,8 EM yes resp distress of 
nb no 127 94 93
61 412627 1,2 30 m 2 nvd pvt hos 15.3 hypothyroid 7,8 EM yes rds/pt/lbw yes 93 78 62
62 412619 3 38 f 6 nvd pvt hos 10.3 nil 8,8 EM yes sepsis no 89 84 64
63 412682 2.5 40 f 1 nvd rmh 15,3 nil 8,8 EM yes resp distress of 
nb no 144 132 88
64 412761 1.2 28 m 1 nvd rmh 16.3 anemia 6,7 im yes rds/pt/lbw no 322 286 289
65 412655 1.2 32 m 1 nvd home 15,3 nil 8,8 EM yes rds/pt/lbw no 84 72 70
66 412475 3 38 m 6 lscs rmh 14.3 short primi 8,8 im yes nnh no 70 71 58
67 412043 3 38 f 1 outlet forceps rmh 11.3 nil 8,8 im yes msaf/resp dist no 130 122 86
68 412471 2.7 38 m 18 nvd vellankudi phc 26,2 nil 8,8 EM yes sepsis no 48 32 85
69 411605 3.5 38 m 1 lscs rmh 8.3 nil 6,8 im yes resp distress of 
nb no 58 70 116
70 411305 2.5 39 m 1 nvd ammapettai phc 5.3 nil 5,6 EM no birth asphyxia no 98 178 75
71 411682 2.6 38 f 2 outlet forceps rmh 8.3 nil 8,8 im yes
resp distress of 
nb no 151 115 90
72 411681 4.1 39 m 2 lscs rmh 8.3 nil 8,8 im yes resp distress of 
nb no 98 81 90
73 416264 1.6 30 m 1 lscs rmh 21.5 abrubtion 7,8 im yes resp distress of 
nb yes 128 116 92
74 419288 3.1 40 m 4 lscs rmh 29.4 nil 8,8 im yes sepsis no 36 34 68
75 419274 2.3 40 m 1 lscs rmh 2.5 nil 7,7 im yes resp distress of 
nb no 136 108 92
76 417832 3 40 m 7 nvd rmh 25.4 nil 8,8 im yes resp distress of 
nb no 92 74 84
77 419262 1.8 32 f 5 lscs pvt hos 27.4 pih 7,8 EM yes hypoglycemia no 92 54 64
78 412343 1.7 34 f 1 lscs rmh 3,5 anemia 8,8 im yes rds/pt/lbw no 108 94 78
79 419245 2.3 37 m 1 lscs rmh 3.5 prom 8,8 im yes resp distress of 
nb no 108 146 116
80 412422 3 38 m 2 lscs rmh 19.5 nil 8,8 im yes resp distress of 
nb yes 60 62 54
81 1187 2.2 34 m 8 lscs rmh 13.5 nil 6,7 im no birth asphyxia no 86 72 54
82 1191 2.5 37 f 8 lscs rmh 11.5 nil 5,7 im yes sepsis no 52 78 64
83 1145 2.9 40 m 3 nvd rmh 18.5 nil 5,8 im yes resp distress of 
nb no 86 72 64
84 421316 3 40 m 3 nvd rmh 18.5 nil 8,8 im yes sepsis no 346 389 380
85 1213 2.9 40 m 5 lscs rmh 16.5 nil 3,6 im no birth asphyxia no 92 104 68
86 418983 2.7 39 m 3 lscs rmh 1.5 nil 8,8 im yes sepsis no 94 138 101
87 1123 1.95 37 m 14 lscs rmh 8.5 pih 1,3 im no birth asphyxia yes 96 108 60
88 420576 1.3 30 f 8 lscs rmh 13.5 opacenta previa 6,8 im yes resp distress of 
nb yes 60 60 58
89 421007 1.5 32 m 1 lscs rmh 17.5 pih 6,7 im yes nnh rd 49 72 60
90 420140 2.3 38 f 10 lscs pvt hos 9.5 nil 6,8 EM no birth asphyxia yes 88 90 62
91 411959 3 38 f 4 nvd rmh 10.3 nil 6,7 im no birth asphyxia no 60 51 72
92 412681 2.75 38 f 1 nvd rmh 17,3 prom 8,8 im yes meningomyeoce
e
no 113 115 108
93 412796 2.5 38 m 4 lscs pvt hos 15.3 oligohydramino
s
8,8 EM yes anomalous baby no 43 27 40
94 424692 2.5 38 f 1 nvd rmh 9.6 pih na,na im yes resp distress of 
nb no 72 50 59
95 427077 1.2 32 f 1 nvd kumbakonam gh 4.6 nil na,na EM yes rds/pt/lbw yes 33 32 36
96 424717 1.5 34 m 23 nvd mannarkudi gh 17.5 nil na,na EM yes rds/pt/lbw yes 23 23 18
97 423751 2.9 38 f 1 lscs rmh 3.6 prev lscs 4,6 im no birth asphyxia yes 72 64 53
98 424480 2 38 f 4 nvd ariyalur gh 4.6 nil na,na EM yes thrombocytopenia no 90 86 72
99 412627 1,2 30 m 2 nvd pvt hos 15.3 hypothyroid 7,8 EM yes rds/pt/lbw yes 98 76 67
100 428849 1.5 32 f 1 lscs rmh 23,6 pih 6,8 im yes lbw no 76 100 86
101 434026 1.5 30 f 9 lscs rmh 29.6 nil 8,8 im yes rds/pt/lbw no 26 62 37
102 424662 2.7 40 f 1 nvd jayamkondam gh 9.6 nil 5,6 EM no birth asphyxia no 62 54 42
103 427066 2.4 36 m 14 nvd jayamkondam gh 23.5 nil 7,8 EM yes sepsis no 84 64 70
104 424813 1.8 36 m 4 nvd pvt hos 6.6 pih 8,8 EM yes hypoglycemia no 45 40 28
105 423519 2.9 40 m 16 lscs pvt hos 16.5 cpd 8,8 EM yes sepsis no 72 56 70
106 427455 2.5 38 m 1 nvd rmh 14.6 prom na,na im yes sepsis no 68 74 68
107 525053 1.8 34 m 1 nvd pvt hos 13-Jun nil 5,7 EM yes rds/pt/lbw no 112 112 148
108 425062 2.5 35 m 1 nvd rmh 14.6 nil na,na im yes rds/pt/lbw no 38 22 40
109 433384 1.5 33 f 1 nvd tiruvarur gh 28.6 nil na,na EM yes rds/pt/lbw no 78 66 49
110 434726 1 38 f 1 nvd rmh 5.6 nil 2,4 im no birth asphyxia no 66 78 58
111 434026 1.5 32 f 8 lscs rmh 29.6 pih 4,6 im yes rds/pt/lbw no 90 98 72
112 435026 1.8 30 f 1 nvd pvt hos 7.6 abrubtion 3,8 EM yes resp distress of 
nb yes 98 88 78
113 417539 2.3 38 f 1 nvd rmh 22.4 nil na,na im yes resp distress of 
nb no 82 74 68
114 421567 1.8 35 m 5hrs lscs rmh 20.5 preeclampsia, hypothyroid im yes rds/pt/lbw no 96 80 62
115 433290 2.3 36 f 1 nvd rmh 24.5 gdm 3,6 im yes rds/pt/lbw no 110 94 90
116 435303 2.72 38 f 4 nvd ariyalur gh 5.6 nil 5,6 EM yes sepsis yes 36 68 34
117 435383 2.5 38 f 3 nvd pvt hos 6.6 nil 5,7 EM yes sepsis no 98 76 50
118 435253 1.2 30 m 1 nvd pvt hos 9.6 abrubtion 5,6 EM yes rds/pt/lbw yes 72 56 54
119 435254 1.4 28 m 1 nvd pvt hos 9.6 abrubtion 5,8 EM yes rds/pt/lbw no 42 24 31
120 435348 2.8 38 m 1 nvd rmh 8,8 abrubtion 7,8 im yes resp distress of 
nb no 96 90 92
121 435379 1.5 32 m 1 lscs pvt hos 9.6 nil 5,7 EM yes rds/pt/lbw no 31 24 20
122 435381 2.1 38 f 1 lscs rmh 9.6 pih 4,6 im yes downs no 96 84 90
123 413438 3.1 39 m 1 nvd pvt hos 20.3 nil 8,8 EM yes resp distress of 
nb no 74 56 50
124 412043 3 38 f 1 outlet forceps rmh 11.3 nil 8,8 im yes msaf/resp dist no 130 122 86
125 412619 3 38 f 6 nvd pvt hos 10.3 nil 8,8 EM yes nnh no 89 88 64
126 412682 2.5 40 f 1 nvd rmh 15.3 nil 8,8 im yes resp distress of 
nb no 144 132 88
127 434934 3 38 m 2 lscs tiruvarur gh 5.6 gdm 4,6 EM no birth asphyxia no 98 110 110
128 435335 2 36 f 1 nvd rmh 9.6 nil 4,6 im no birth asphyxia no 132 136 128
129 433724 1.2 28 m 1 nvd rmh 28.5 pih 3,5 im no birth asphyxia no 106 94 86
130 433723 1.2 30 m 1 nvd rmh 28,5 pih 3,5 im no birth asphyxia no 76 64 58
131 434748 4 38 f 1 lscs rmh 3,7 pih 5,7 im yes resp distress of 
nb 108 102 94
132 413438 3.1 39 m 2 nvd pvt hos 20.3 nil 8,8 EM yes resp distress of 
nb no 127 94 93
133 434521 2.3 38 f 1 nvd rmh 6.6 nil 8,8 im yes msaf/resp dist no 78 76 70
134 434818 2.4 34 f 1 lscs rmh 6.6 pih 4,6 im yes rds/pt/lbw no 36 28 26
135 412761 1.2 28 m 1 nvd rmh 16.3 anemia 6,7 im yes rds/pt/lbw no 312 262 302
136 412655 1.2 34 m 1 nvd rmh 15.3 nil 8,8 im yes rds/pt/lbw no 84 72 70
137 412475 3 38 m 7 lscs rmh 14.3 nil 8,8 im yes nnh no 70 77 58
138 434067 3.3 38 m 2 lscs rmh 30,5 hypothyroid 8,8 im yes sepsis no 56 64 51
139 435243 2.4 34 m 1 lscs rmh 9.6 hypothyroid 7,8 im yes rds/pt/lbw no 78 68 64
140 434691 2.25 38 f 24 lscs kumbakonam gh 11.5 nil 4,6 EM yes sepsis no 68 40 56
141 412627 1.2 30 m 2 nvd pvt hos 15.3 hypothyroid 7,8 EM yes rds/pt/lbw no 20 24 26
142 412679 1.8 39 m 2 nvd rmh 17.3 nil 6,7 im yes anomalous baby no 63 32 37
143 437546 2.2 38 f 6 lscs rmh 2.6 nil 4,6 im yes birth asphyxia no 68 56 58
144 434940 2.7 38 m 2 nvd rmh 6,6 nil 4,6 im yes msaf/resp dist no 56 72 60
145 425215 2.2 39 f 12 nvd pvt hos 28.5 nil na,na EM yes sepsis no 72 58 60
146 434723 2.3 34 m 3 lscs rmh 5.6 pih 4,6 im no birth asphyxia no 62 56 50
147 434629 2.5 38 f 22 nvd ariyalur gh 15.5 nil 5,7 EM yes msaf/resp dist no 78 64 68
148 433277 1.3 32 m 5 nvd rmh 24.5 pih 3,5 im no birth asphyxia no 60 56 48
149 434814 2.7 39 m 2 nvd rmh 5,6 pih na,na im yes hypoglycemia no 28 28 20
150 431907 2.5 37 m 2 lscs rmh 6.6 nil 7,8 im yes sepsis no 88 77 77
151 434929 1.5 36 f 1 nvd rmh 6.6 nil 6,6 im no birth asphyxia yes 68 74 68
152 434697 2.8 38 f 23 nvd pvt hos 12.5 gdm 4,6 EM yes hypoglycemia no 38 36 33
153 434769 2.5 39 f 8 nvd kumbakonam gh 29.5 nil 8,8 EM yes sepsis no 80 76 76
154 433259 2.3 34 m 21 nvd kumbakonam gh 3.5 nil na,na EM yes sepsis no 66 58 54
155 434675 1.7 35 f 1 nvd rmh 4.6 pih na,na im yes rds/pt/lbw no 128 112 97
156 434028 1.5 32 f 10 nvd rmh 29.5 nil 8,8 im yes rds/pt/lbw no 90 94 72
157 435716 2 30 m 1 nvd rmh 18.6 pih 4,5 im no birth asphyxia no 48 24 35
158 435342 1.7 34 m 1 lscs rmh 10.8 pih 4,8 im yes hypoglycemia no 43 36 20
159 436160 1.6 37 m 1 lscs 16.6 r pih 5,8 im yes rds/pt/lbw no 40 36 27
160 435841 1.9 32 m 1 lscs rmh 14.6 pih 4,7 im yes rds/pt/lbw no 77 65 62
161 435840 2.14 32 f 1 lscs rmh 14.8 pih 3,8 im yes rds/pt/lbw no 90 56 68
162 435714 1.75 30 m 1 nvd rmh 13.6 pih 3,8 im yes rds/pt/lbw yes 76 58 54
163 436882 2.3 36 f 1 lscs rmh 21.6 gdm 5,7 im yes rds/pt/lbw no 34 28 23
164 436216 2.2 32 m 4 lscs rmh 13.6 abrubtion 4,8 im yes rds/pt/lbw yes 66 54 56
165 436006 2.2 34 f 1 nvd rmh 16.6 prom 3,6 im yes sepsis no 43 37 31
166 436842 3 38 f 1 lscs rmh 21.6 hypothyroid 5,6 im yes meningomyeoce
e
no 68 76 64
167 436155 2.5 36 f 1 nvd pvt hos 16.6 nil 2,3 EM no birth asphyxia yes 54 58 52
168 435683 2.6 39 f 7 nvd rmh 13.6 pih 5,8 im yes nnh no 66 64 50
169 436679 3.5 38 f 1 nvd ariyalur gh 19,6 pih 4,6 EM no birth asphyxia yes 28 26 26
170 436062 3.5 40 f 1 nvd mannarkudi gh 15.6 anemia 5,8 EM yes hdn no 76 78 72
171 436844 2.8 39 f 1 nvd pvt hos 20.6 nil 5,8 EM yes sepsis no 58 62 59
172 436200 2 39 f 2 lscs rmh 17.6 hypothyroid 4,8 im yes sepsis no 86 77 75
173 436983 3.1 38 m 2 nvd rmh 15.6 prom 5,7 im yes hypoglycemia no 33 32 36
174 436179 3.7 38 m 1 lscs mannarkudi gh 16.6 hypothyroid 5,8 EM yes chd no 67 68 59
175 436463 3 38 m 9 nvd kumbakonam gh 9.6 hypothyroid 4,7 EM yes sepsis no 64 78 67
176 436069 4 38 m 13 nvd ariyalur gh 3,6 gdm 6,8 EM yes chd no 64 56 56
177 435363 2.7 39 m 3 nvd rmh 9.6 pih 6.8 im yes nnh no 112 102 90
178 409046 2.75 40 m 2 nvd rmh 14.6 prom 4,7 im yes sepsis yes 132 64 62
179 436972 2 34 f 20 nvd kumbakonam gh 31.5 pih 4,6 EM yes rds/pt/lbw no 154 128 115
180 436467 3 39 m 1 nvd rmh 17.6 polyhydraminos 2,5 im no birth asphyxia yes 88 76 75
181 436493 0.75 26 m 1 nvd rmh 18.6 pih 3,6 im yes rds/pt/lbw no 137 145 126
182 436760 0.99 28 m 1 nvd rmh 20.6 pih 4,8 im yes rds/pt/lbw yes 23 20 31
183 436894 2.4 36 m 1 lscs ariyalur gh 21.6 pih 5,8 EM yes rds/pt/lbw no 77 56 54
184 427761 2.8 38 f 1 nvd rmh 16.6 nil 3,7 im yes sepsis no 118 124 104
185 411682 2.6 38 f 2 outlet forceps rmh 8.3 nil 8,8 im yes
resp distress of 
nb no 76 115 67
186 418983 2.7 39 m 3 lscs rmh 1.5 nil 8,8 im yes sepsis no 26 28 33
187 421624 2.1 37 m 1 lscs rmh 21,5 idm 8,8 im yes sepsis no 38 39 30
188 435335 2 36 f 1 nvd rmh 9.6 nil 4,6 im no birth asphyxia no 132 136 126
189 417539 2.3 38 f 1 nvd rmh 22.4 nil na,na im yes resp distress of 
nb no 82 74 56
190 436006 2.2 34 f 1 nvd rmh 16.6 prom 3,6 im yes sepsis no 77 88 87
191 434691 2.25 38 f 24 lscs kumbakonam gh 11.5 nil 4,6 EM yes sepsis no 38 33 24
192 416927 2.8 40 m 3 nvd rmh 22.6.16 nil 8,8 im yes sepsis no 85 88 98
193 411681 4.1 39 m 2 lscs rmh 8.3 nil 8,8 im yes resp distress of 
nb no 98 81 90
194 427077 1.2 32 f 1 nvd kumbakonam gh 4.6 nil na,na EM yes rds/pt/lbw yes 52 44 46
195 424717 1.5 34 m 23 nvd mannarkudi gh 17.5 nil na,na EM yes rds/pt/lbw yes 146 140 120
196 435714 1.75 30 m 1 nvd rmh 13.6 pih 3,8 im yes rds/pt/lbw yes 53 48 48
197 427497 1 28 f 8 nvd rmh 15,6 nil 4,7 im yes rds/pt/lbw no 116 113 112
198 421567 1.7 32 m 3 nvd rmh 17.6.16 nil 8,9 im yes sepsis no 84 78 56
199 436160 1.6 34 m 1 lscs 16.6 r pih 5,8 im yes rds/pt/lbw no 23 36 32
200 435840 2.14 32 f 1 lscs rmh 14.8 pih 3,8 im yes rds/pt/lbw no 76 65 59
